Luiza Lassi Puglia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luiza Lassi Puglia has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Fabián Andrés Hurtado
Laboratory of Molecular Biology of Fungi, University of Brasilia, Brasilia 70910-900, Brazil
1 shared publication - Fernanda Fonsêca Ferreira
Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasília 70.910-900, Brazil
1 shared publication - Ildinete Silva-Pereira
Laboratory of Molecular Biology of Pathogenic Fungi, Department of Cell Biology, Institute of Biological Sciences, University of Brasília, UnB, Brasília 70910-900, DF, Brazil
1 shared publication - Kunal Ranjan
Division of Microbiology, ICAR-Indian Agricultural Research Institute, New Delhi, 110012, India
1 shared publication - Larissa Fernandes
Laboratory of Food, Drugs, and Cosmetics (LTMAC), School of Health Sciences, University of Brasília, Brasília 70910-900, Brazil
1 shared publication - Marcio José Poças-Fonseca
Department of Genetics and Morphology, Institute of Biological Sciences (IB), University of Brasilia (UnB), Brasilia, 70910-900, Brazil.
1 shared publication
Latest Publications
- Open Access
- 12 February 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (2) , 133
Base Excision Repair AP-Endonucleases-Like Genes Modulate DNA Damage Response and Virulence of the Human Pathogen Cryptococcus neoformans
Pathogenic microbes are exposed to a number of potential DNA-damaging stimuli during interaction with the host immune system. Microbial survival in this situation depends on a fine balance between the maintenance of DNA integrity and the adaptability provided by mutations. In this study, we investigated the association of the DNA repair response with the virulence of Cryptococcus neoformans, a basidiomycete that causes life-threatening meningoencephalitis in immunocompromised individuals. We focused on the characterization of C. neoformansAPN1 and APN2 putative genes, aiming to evaluate a possible role of the predicted Apurinic/apyrimidinic (AP) endonucleases 1 and 2 of the base excision repair (BER) pathway on C. neoformans response to stress conditions and virulence. Our results demonstrated the involvement of the putative AP-endonucleases Apn1 and Apn2 in the cellular response to DNA damage induced by alkylation and by UV radiation, in melanin production, in tolerance to drugs and in virulence of C. neoformans in vivo. We also pointed out the potential use of DNA repair inhibitor methoxy-amine in combination with conventional antifungal drugs, for the development of new therapeutic approaches against this human fungal pathogen. This work provides new information about the DNA damage response of the highly important pathogenic fungus C. neoformans.
- 12 February 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (2) , 133
Open AccessBase Excision Repair AP-Endonucleases-Like Genes Modulate DNA Damage Response and Virulence of the Human Pathogen Cryptococcus neoformans
Pathogenic microbes are exposed to a number of potential DNA-damaging stimuli during interaction with the host immune system. Microbial survival in this situation depends on a fine balance between the maintenance of DNA integrity and the adaptability provided by mutations. In this study, we investigated the association of the DNA repair response with the virulence of Cryptococcus neoformans, a basidiomycete that causes life-threatening meningoencephalitis in immunocompromised individuals. We focused on the characterization of C. neoformansAPN1 and APN2 putative genes, aiming to evaluate a possible role of the predicted Apurinic/apyrimidinic (AP) endonucleases 1 and 2 of the base excision repair (BER) pathway on C. neoformans response to stress conditions and virulence. Our results demonstrated the involvement of the putative AP-endonucleases Apn1 and Apn2 in the cellular response to DNA damage induced by alkylation and by UV radiation, in melanin production, in tolerance to drugs and in virulence of C. neoformans in vivo. We also pointed out the potential use of DNA repair inhibitor methoxy-amine in combination with conventional antifungal drugs, for the development of new therapeutic approaches against this human fungal pathogen. This work provides new information about the DNA damage response of the highly important pathogenic fungus C. neoformans.